NCT05736588View on ClinicalTrials.gov

Elimisha HPV (Human Papillomavirus)

NACompletedINTERVENTIONAL
Enrollment

982

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

November 26, 2024

Study Completion Date

November 26, 2024

Conditions
Cervical CancerHPVHIVStigma
Interventions
BEHAVIORAL

Elimisha HPV

Elimisha HPV is a multi-level stigma-responsive cervical cancer prevention service delivery model that incorporates stigma-responsive education, peer navigation and a patient-centered delivery strategy, addressing drivers while mitigating harms from stigma.

Trial Locations (1)

Unknown

Kenya Medical Research Institute, Kisumu

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

Duke University

OTHER

NCT05736588 - Elimisha HPV (Human Papillomavirus) | Biotech Hunter | Biotech Hunter